OUR LATEST INVESTOR INFORMATION
Crystal Research Associates Executive Informational Overview, March 10, 2022
Download PDF
COMPANY PROFILE

FSD Pharma is a life sciences holding company dedicated to building a portfolio of diversified therapeutic assets and innovative healthcare and biotech services. The Company is currently advancing a pipeline of innovative therapeutics that target Total Brain Health with multiple lead clinical candidates addressing a variety of neurodegenerative and neuropsychiatric diseases.

Through its wholly-owned subsidiary, Lucid Psycheceuticals, FSD has exclusive worldwide rights to novel compounds shown to reverse the underlying cause of progressive Multiple Sclerosis. Additionally, FSD is developing a unique psychedelic-based therapeutic aimed to address a multibillion-dollar mental health market. The Company plans to quickly advance its lead drug candidates through clinical trials to one day change the minds and bodies of millions of patients for the better.

Industry classifications

Sector:

Healthcare

Industry:

Drug Manufacturers

NAICS:

Pharmaceutical
Preparation
Manufacturing (325412)

SIC:

Pharmaceutical and
Medicine Industry
(3741)

Stock data
Market Data copyright © 2021 QuoteMedia.
Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
RT=Real-Time, EOD=End of Day, PD=Previous Day.
Market Data powered by QuoteMedia. Terms of Use.
Financial results
Q1 2022
CONDENSED CONSOLIDATED INTERIM STATEMENTS OF FINANCIAL STATEMENTS for the three months ended March 31, 2022, and 2021
Earnings Release
PDF
SEC filling
Latest quarterly or annual filing
Annual reports filed by certain Canadian issuers pursuant to Section 15(d) and Rule 15d-4

DECEMBER 31, 2021
20-F
Latest current report
Condensed consolidated interim financial statements for the three months ended March 31, 2022, and 2021

MAY 13, 2022
PDF
PDF
Company Structure
Our leadership consists of a passionate management team with diverse industry knowledge, committed to science, therapeutic drug discovery and development.
BOARD OF DIRECTORS
...
EXPERT RESEARCH AND CLINICAL TEAM
...
MANAGEMENT TEAM
...
REGULATORY ADVISORY BOARD
...
Governance Documents
CODE OF CONDUCT AND ETHICS PDF
NASDAQ CORPORATE GOVERNANCE DISCLOSURE STATEMENT PDF
FAQ
  • What is FSD Pharma Inc.'s stock symbol?

    Our stock is traded on the CSE under the symbol HUGE and on the Nasdaq under the symbol HUGE.
  • When was FSD Pharma Inc. incorporated?

    November 1, 1998
  • When did FSD Pharma Inc. become a public company?

    May 29, 2018
  • When is FSD Pharma Inc.'s fiscal year end?

    December 31st
  • Who is FSD Pharma Inc.'s transfer agent?

    Marrelli Support Services Inc. (MSSI)
  • Who is FSD Pharma Inc.'s independent auditor?

    MNP LLP
  • Who is FSD Pharma Inc.'s outside legal counsel?

    Blake, Cassels & Graydon LLP

Receive most valuable updates straight into your inbox

SIGN UP TODAY



PLEASE SEND INVESTOR INQUIRIES TO [email protected],
ALL OTHER INQUIRIES PLEASE EMAIL TO [email protected]@FSDPHARMA.COM

JOIN OUR TEAM

Careers

    Email Alerts

    Please fill out the form below to receive company press releases via email when they occur.


    Contact

      TOP